Cue Biopharma, Inc.
NASDAQ:CUE
0.565 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.49 | 1.245 | 14.941 | 3.154 | 3.458 | 1.143 | 0 | 0 | 0 |
| Cost of Revenue
| 3.436 | 1.806 | -1.778 | 33.546 | 27.487 | 28.544 | 0.42 | 0.202 | 0.045 |
| Gross Profit
| 2.054 | -0.561 | 16.719 | -30.391 | -24.029 | -27.401 | -0.42 | -0.202 | -0.045 |
| Gross Profit Ratio
| 0.374 | -0.45 | 1.119 | -9.635 | -6.949 | -23.982 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 40.276 | 38.578 | 41.347 | 33.546 | 27.487 | 28.544 | 18.9 | 5.688 | 1.504 |
| General & Administrative Expenses
| 16.68 | 16.169 | 17.307 | 14.651 | 12.74 | 11.295 | 4.334 | 1.97 | 0.425 |
| Selling & Marketing Expenses
| -2.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 13.77 | 16.169 | 17.307 | 14.651 | 12.74 | 11.295 | 4.334 | 1.97 | 0.425 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0.064 | 0.165 | 0 | 0 | 0 |
| Operating Expenses
| 54.046 | 54.747 | 58.653 | 48.197 | 40.227 | 39.839 | 23.234 | 7.658 | 1.929 |
| Operating Income
| -51.992 | -53.225 | -43.712 | -45.043 | -36.769 | -38.697 | -23.234 | -7.658 | -1.929 |
| Operating Income Ratio
| -9.47 | -42.743 | -2.926 | -14.28 | -10.633 | -33.867 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.259 | 0.214 | 0.046 | 0.464 | 0.483 | 0.165 | 0 | 0 | 0 |
| Income Before Tax
| -50.733 | -53.01 | -43.666 | -44.579 | -36.286 | -38.155 | -23.234 | -7.658 | -1.929 |
| Income Before Tax Ratio
| -9.241 | -42.571 | -2.923 | -14.133 | -10.493 | -33.393 | 0 | 0 | 0 |
| Income Tax Expense
| 3.268 | -0.214 | 0.495 | 0.206 | 0.412 | 0.825 | 0 | 0 | 0 |
| Net Income
| -50.733 | -52.796 | -44.161 | -44.785 | -36.698 | -38.98 | -23.234 | -7.658 | -1.929 |
| Net Income Ratio
| -9.241 | -42.399 | -2.956 | -14.198 | -10.612 | -34.115 | 0 | 0 | 0 |
| EPS
| -1.11 | -1.48 | -1.41 | -1.56 | -1.66 | -1.94 | -1.13 | -0.37 | -0.093 |
| EPS Diluted
| -1.11 | -1.48 | -1.41 | -1.56 | -1.66 | -1.94 | -1.13 | -0.37 | -0.093 |
| EBITDA
| -48.556 | -50.767 | -43.712 | -43.985 | -36.769 | -37.937 | -22.814 | -7.456 | -1.884 |
| EBITDA Ratio
| -8.844 | -40.769 | -2.926 | -13.944 | -10.633 | -33.202 | 0 | 0 | 0 |